# Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

> **NCT00904241** · — · ACTIVE_NOT_RECRUITING · sponsor: **Children's Oncology Group** · enrollment: 10000 (estimated)

## Conditions studied

- Ganglioneuroblastoma
- Localized Resectable Neuroblastoma
- Localized Unresectable Neuroblastoma
- Regional Neuroblastoma
- Stage 4 Neuroblastoma
- Stage 4S Neuroblastoma

## Interventions

- **OTHER:** Cytology Specimen Collection Procedure
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT00904241
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2000-11-06
- **Primary completion:** 2100-01-01
- **Final completion:** —
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2025-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00904241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00904241, "Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00904241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*